Cell biology of diabetic kidney disease

Nephron - Experimental Nephrology

Volumn 101, Issue 3, 2005, Pages

  Kanwar, Yashpal S ^a   Akagi, Shigeru ^a   Sun, Lin ^a   Nayak, Baibaswata ^a   Xie, Ping ^a   Wada, Jun ^b   Chugh, Sumant S ^a   Danesh, Farhad R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Guanosine triphosphate binding proteins; Hyperglycemia; Protein kinase C; Reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CELL CYCLE PROTEIN; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN INHIBITOR; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL CYCLE; CELL DAMAGE; CELL METABOLISM; CELL TRANSFORMATION; CELL TYPE; CHRONIC DISEASE; CYTOLOGY; DIABETIC NEPHROPATHY; EPITHELIUM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; MESENCHYME; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; HYPERGLYCEMIA; KIDNEY;

EID: 27544483644     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087339     Document Type: Short Survey

References (56)

1. LeRoith D, Taylor SI and Olefsky JM: Diabetes mellitus: A Fundamental and Clinical Text, ed 3. Philadelphia, Lippincott William & Wilkins, 2004, pp 1-1540.
2. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2000;414:813-820.
3. Sheetz MJ, King GL: Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579-2588.
4. Chugh SS, Wallner El, Kanwar YS: Renal development in high-glucose ambience and diabetic embryopathy. Semin Nephrol 2003;23:583-592.
5. Reddy AS: Diabetic Nephropathy: Theory and Practice. East Hanover, College Book Publishers, 2004. pp 1-563.
6. Parving H-H, Osterby R, Ritz E: Diabetic nephropathy; in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 2000, pp 1731-1773.
7. Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003;14:1358-1373.
8. Heilig CW, Brosius FC, Henry DN: Glucose transporters of the glomerulus and the implications for diabetic nephropathy. Kidney Int 1997;60:S91-S99.
9. Nelson DL, Cox MM: Glycolysis and catabolism of hexoses; The citric acid cycle. Lehninger Principles of Biochemistry. New York, Worth, 2000, pp 527-597.
10. Schleicher ED, Weigert C: Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int 2000;58(suppl 77): S13-S18.
11. Chung SS, Ho EC, Lam KS, Chung SK: Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003;14(suppl 3):S233-S236.
12. Arner RJ, Prabhu KS, Thompson JT, Hildenbrandt GR, Linken AD, Reddy CC: Myo-inositol oxygenase: Molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. Biochem J 2001;300:313-320.
13. Yang Q, Dixit B, Wada J, Tian Y, Wallner EI, Srivastva SK, Kanwar YS: Identification of a renal-specific oxido-reductase in newborn diabetic mice. Proc Natl Acad Sci USA 2000;97:9896-9901.
14. +ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599-606.
15. +ATPase regulation involved in pathogenesis of diabetic neuropathy. Diabetes 1988;37:688-693.
16. Ziyadeh FN, Simmons DA, Snipes ER, Goldfarb S: Effect of myoinositol on cell proliferation and collagen transcription and secretion in proximal cells cultured in elevated glucose. J Am Soc Nephrol 1991;1:1220-1229.
17. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995;46:223-234.
18. Schleicher ED, Bierhaus A, Haring HU, Nawroth PP, Lehmann R: Chemistry and pathobiology of advanced glycation end products; in D'Angelo A, Favaro S, Gambaro G (eds): Advanced Glycation End Products in Nephrology. Contrib Nephrol. Basel, Karger, 2001, vol 131, pp 1-9.
19. Sakurai S, Yonekura H, Yamamoto Y, Watanabe T, Tanaka N, Li H, Rahman AK, Myint KM, Kim CH, Yamamoto H: The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol 2003;14(suppl 3):S259-S263.
20. Jakus V, Rietbrock N: Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004;53:131-142.
21. Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, Haller H, Cooper ME, Forbes JM: Attenuation of extracellular matrix accumulation in diabetic nephropathy by advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α-dependent pathway. Diabetes 2004;53:2921-2930.
22. Forbes JM, Cooper ME, Oldfield MD, Thomas MC: Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003;14(suppl 3):S254-S258.
23. Whiteside CI, Dlugosz JA: Mesangial cell protein kinase C isozyme activation in diabetic milieu. Am J Physiol Renal Physiol 2002;282:F975-F980.
24. Parker PJ, Murray-Rust J: PKC at a glance. J Cell Sci 2004;117:131-132.
25. Inoguchi T, Sonta T, Tsubouchi H, Eton T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H: Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 2003;14(suppl 3):S227-S232.
26. Leask A, Abraham DJ: TGF-β signaling and the fibrotic response. FASEB J 2004;18:816-827.
27. Schiffer M, von Gersdorf G, Bitzer M, Susztak K, Bottinger EP: Smad proteins and transforming growth factor-β signaling. Kidney Int 2000;58(suppl 77):S45-S52.
28. Ziyadeh FN: Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 2004;15(suppl 1):S55-S57.
29. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274:5830-5834.
30. Takai Y, Sasaki T, Matozaki T: Small GTP-binding proteins. Physiol Rev 2001;81:153-208.
31. Kim SL, Kim HJ, Han DC, Lee HB: Effect of lovastatin on small GTP binding proteins and TGF-β 1 and fibronectin expression. Kidney Int 2000;58(suppl 77):S88-S92.
32. Sharpe CC, Hendry BM: Signaling: Focus on Rho in renal disease. J Am Soc Nephrol 2003;14:261-264.
33. Lin S, Sahai A, Chugh SS, Pan X, Wallner EI, Danesh FR, Lomasney JW, Kanwar YS: High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b and B-Raf signaling pathway. J Biol Chem 2002;277:41725-41735.
34. Lin S, Chugh SS, Pan X, Wallner EI, Wada J, Kanwar YS: Identification of up-regulated Ras-like GTPase, Rap1b, by suppression subtractive hybridization. Kidney Int 2001;60:2129-2141.
35. Danesh FR, Sadeghi MM, Amro N, Philips C, Zeng L, Lin S, Sahai A, Kanwar YS: HMG-CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase p21 signaling pathway: Implications for diabetic nephropathy. Proc Natl Acad Sci USA 2002;99:8301-8305.
36. Zeng L, Xu H, Chew T-L, Chisholm R, Sadeghi MM, Kanwar YS, Danesh FR: Simvastatin modulates angiotensin II signaling pathway by preventing Rac1-mediated upregulation of p27. J Am Soc Nephrol 2004;15:1711-1720.
37. Wolf G: Molecular mechanism of diabetic mesangial cell hypertrophy: a proliferation of novel factors. J Am Soc Nephrol 2002;13:2611-2613.
38. Werner E: GTPases and reactive oxygen species: switches for killing and signaling. J Cell Sci 2004;117:143-153.
39. Djordjevic VB: Free radicals in cell biology. Int Rev Cytol 2004;237:57-89.
40. Radi R, Cassina A, Hodara R, Quijano C, Castro L: Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002;33:1451-1464.
41. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M: Effects of antioxidants in diabetes-induced oxidative stress in glomeruli of diabetic rats. J Am Soc Nephrol 2003;14(suppl 3):S250-S253.
42. Li JM, Shah AM: ROS generation by non-phagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003;14(suppl 3):S221-S226.
43. Kang D, Hamasaki N: Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med 2003;41:1281-1288.
44. Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity and mitochondrial damage in type 2 diabetes. Diabetes 2004;53:1412-1417.
45. Lee HB, Yu MI-RA, Yang Y, Jiang Z, Ha H: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003;14(suppl 3):S241-S245.
46. Phillips AO: The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep 2003;3:491-496.
47. Maassen JA, Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir RS, Raap AK, Janssen GM, Lemkes HH: Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 2004;53(suppl 1):S103-S109.
48. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E: Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells. Diabetes 2003;52:2570-2577.
49. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 2001;50:2114-2125.
50. DeRubertis FR, Craven PA, Melhem MF, Salah EM: Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: Evidence for reduced superoxide-nitric oxide interaction. Diabetes 2004;53:762-768.
51. Vasquez-Vivar J, Kalyanaraman B, Martasek P: The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res 2003;37:121-127.
52. Scott-Burden T: Regulation of nitric oxide production by tetrahydropterin. Circulation 1995;91:248-250.
53. Cosentino F, Katusic Z: Tetrahydrobiopterin and dysfunction of the endothelial nitric oxide synthase in coronary arteries. Circulation 1995;91:139-144.
54. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000;87:840-844.
55. Pieper GM: Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol 1997;29:8-15.
56. Wallace DC: Mitochondrial diseases in man and mouse. Science 1999;283:1482-1428.